We are live on ! Find out more
FP

Foundry Partners Portfolio holdings

AUM $1.89B
1-Year Est. Return 9.84%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.99B
AUM Growth
-$31M
Cap. Flow
+$2.59M
Cap. Flow %
0.13%
Top 10 Hldgs %
17.9%
Holding
309
New
25
Increased
122
Reduced
118
Closed
40

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$22.7M
2
PFE icon
Pfizer
PFE
+$21.5M
3
DGX icon
Quest Diagnostics
DGX
+$16.8M
4
MOS icon
The Mosaic Company
MOS
+$15.1M
5
HWC icon
Hancock Whitney
HWC
+$13.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$16M
2
MRK icon
Merck
MRK
+$15.9M
3
LYB icon
LyondellBasell Industries
LYB
+$15.7M
4
PSX icon
Phillips 66
PSX
+$13.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$11.1M

Sector Composition

Rank Sector Weight
1 Financials 24.91%
2 Industrials 16.38%
3 Technology 11.11%
4 Healthcare 10.84%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
301
Phillips 66
PSX
$82.9B
-105,120
Closed -$13.8M
TMHC icon
302
Taylor Morrison
TMHC
$6.67B
-2,864
Closed -$201K
TOL icon
303
Toll Brothers
TOL
$14B
-1,361
Closed -$210K
WAFD icon
304
WaFd
WAFD
$2.72B
-88,098
Closed -$3.07M
WU icon
305
Western Union
WU
$2.57B
-681,002
Closed -$8.12M
AHR icon
306
American Healthcare REIT
AHR
$11.1B
-12,024
Closed -$314K
PDCO
307
DELISTED
Patterson Companies, Inc.
PDCO
-11,931
Closed -$261K
SILV
308
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-577,025
Closed -$5.34M
USAP
309
DELISTED
Universal Stainless & Alloy
USAP
-158,365
Closed -$6.12M

Similar funds

Foundry Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Foundry Partners held 309 positions worth $1.99B, down 1.5% from $2.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Foundry Partners's Q4 2024 filing shows 25 new, 122 increased, 118 reduced and 40 closed positions. Its largest new stake was Bristol-Myers Squibb: 406,683 shares worth $23M. The largest sale was GSK, an estimated $16M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Foundry Partners's largest Q4 2024 buy was Bristol-Myers Squibb: 406,683 shares worth $23M.
  • Foundry Partners added most to Walt Disney in Q4 2024, an estimated $8.81M increase.
  • Foundry Partners's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $11.1M.
  • Foundry Partners fully exited GSK in Q4 2024, selling an estimated $16M.
  • Foundry Partners's ten largest holdings make up 18% of its $1.99B portfolio in Q4 2024.
  • Foundry Partners opened 25 new positions and closed 40 in Q4 2024.
  • Foundry Partners's portfolio value fell 1.5% quarter-over-quarter to $1.99B.

Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.